Description
Carvedilolisanα1-andβ1/2-adrenergicreceptorantagoNISTusedtotreatcongestiveheartfailure;itsinhibitoryactionatadrenergicreceptorsslowsheartrhythm,decreasingforce,pressure,andcardiacworkload.Carvedilolalsoinhibitsreleaseofpro-inflammatorycytokinesTNF-αandIL-6andproductionofeicosanoidsPGE2andLTB4,alleviatingoxidativestressandindicatingantioxidativeandanti-arthriticactivities.Additionally,thiscompoundmayexhibitanti-atheroscleroticandanti-diabeticactivitythroughitsinhibitionofacidsphingomyelinase(FIASMA).